Author:
Wang Lei,Reheman Aikebaier,Wan Chuanxing
Funder
National Natural Science Foundation of China
Autonomous Region Graduate Research Innovation Project，XinJiang, China
The Third Xinjiang Scientific Expedition Program, China
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Bagcchi, S. WHO’s Global Tuberculosis Report 2022. Lancet Microbe 4, e20 (2023).
2. Huynh, J. & Marais, B. J. Multidrug-resistant tuberculosis infection and disease in children: A review of new and repurposed drugs. Ther. Adv. Infect. Dis. 6, 2049936119864737 (2019).
3. Luo, X. et al. Antituberculosis compounds from a deep-sea-derived fungus Aspergillus sp. SCSIO Ind09F01. Nat. Prod. Res. 31, 1958–1962 (2017).
4. Igarashi, M., Ishizaki, Y. & Takahashi, Y. New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development. J. Antibiot. 71, 15–25 (2017).
5. Elad, N. et al. Structure of Type-I Mycobacterium tuberculosis fatty acid synthase at 3.3 Å resolution. Nat. Commun. 9, 3886 (2018).